Category Archives: Corporate

Healthcare stocks roar back after slump, while biotech IPOs continue stampede into pipeline.

The News: Rising healthcare stocks and fading qualms over an escalating Syrian conflict had Wall St. optimistic to start the week. Stocks had ended lower on Friday (April 13, 2018)… Read more »

Heath stock take it on the chin while immuno-oncology IPOs keep a coming.

1. Medical Stock Spotlight 1) Losers far outpaced winners last week with Edge Therapeutics Inc. (Nasdaq:EDGE) nosediving 93% over the week to $1.18. Up until last week, shares of Edge Thera… Read more »

Under the radar: Uber launches health platform to get patients to and from appointments–whether or not they have the app or a smartphone!

The News: UBER Technologies Inc. (San Francisco) is launching a new business line called Uber Health that will provide a ride-hailing platform available specifically to healthcare providers, letting clinics, hospitals,… Read more »

US physicians’ annual economic influence: $2.3 trillion and 12.6 million jobs. Makes me view my GP, specialists in an entirely new light.

The News: Physicians support 12.6 million jobs in the US–17.1 jobs each–and contribute $2.3 trillion to the economy, according to a new report from the American Medical Association (pdf) (AMA)…. Read more »

Ablynx soars 60% on Novo’s latest hostile bid; grab a piece of this Belgian biotech because the real action’s just starting.

The News: Denmark’s Novo Nordisk A/S (Copenhagen), the world’s biggest insulin maker, went public Monday (January 8, 2018) with a €2.6-billion ($3.1 billion) bid for Belgian biotech group Ablynx NV… Read more »

French nanocap Sensorion inks deal with Aussie implant-maker Cochlear for €1.6M capital infusion, R&D collaboration. Pearl by the Mediterranean?

The News: Sensorion SA (Montpellier FRA), a tiny biotech company pioneering novel treatments for inner-ear diseases, and Cochlear Ltd. (Sydney), the global leader in implantable hearing devices, in a joint… Read more »

London-based biotech TopiVert, although invisible, intends to shake up Allergan, Shire in the huge dry-eye space.

The News: TopiVert Pharma Ltd., a clinical-stage biotechnology company developing narrow spectrum kinase inhibitors (NSKIs) for chronic inflammatory gastrointestinal (GI) and ocular diseases, has announced results from a Phase 1/2a… Read more »

Netherlands-based, emerging biotech star arGEN-X gives shareholders two doses of great news; stock skyrockets.

The News: arGEN-X SE (Breda NLD) has smoked its target of $150 million for a US stock offering, which will support its cancer and autoimmune disease antibodies through the clinical phases…. Read more »

Micro biotech Alzinova, hiding out in southwest Sweden, using proprietary peptide technology that targets key Alzheimer’s toxins.

Background: Alzinova AB (Gothenburg) is a Swedish biotechnology company engaged in the discovery and development of therapeutics for the treatment of Alzheimer’s disease (AD). The company was founded in 2011… Read more »